Stieger N, Caira M R, Wessels J C, Liebenberg W
Pharmazie. 2017 Oct 1;72(10):571-574. doi: 10.1691/ph.2017.7043.
Some known nevirapine solvates have been reported to undergo solvent exchange in aqueous media to form a stable hemihydrate. This study aimed to determine the effects of atmospheric moisture on said nevirapine solvates and to gain insight into which factors determine the end product of transformation. Solvates were prepared by solvent recrystallisation and stored, together with the anhydrous and hemihydrate forms, in a climate chamber at 40 °C and 75% RH for a period of 28 days. Samples were analyzed using DSC, TGA, FT-IR, PXRD and Karl Fischer titration. Some solvates were observed to undergo desolvation to the anhydrous form of nevirapine (Form I), whilst others converted to the hemihydrate. It was found that water miscibility of the guest solvent determined the stable form of nevirapine, anhydrous or hemihydrate, to which each solvate eventually transformed. Transformation to the hemihydrate only occurred if the guest solvent was sufficiently water soluble to allow water molecules to enter solvent channels and displace the original guest. Solvates with hydrophobic guests desolvated to the anhydrous form. We concluded that, in the absence of a guest, solvent channels are lost during transformation to the monoclinic crystal system and space group P21/c (Form I) so that water cannot enter after desolvation.
据报道,一些已知的奈韦拉平溶剂化物在水性介质中会发生溶剂交换,形成稳定的半水合物。本研究旨在确定大气湿度对所述奈韦拉平溶剂化物的影响,并深入了解哪些因素决定了转化的最终产物。通过溶剂重结晶制备溶剂化物,并将其与无水形式和半水合物形式一起在气候箱中于40°C和75%相对湿度下储存28天。使用差示扫描量热法(DSC)、热重分析法(TGA)、傅里叶变换红外光谱法(FT-IR)、粉末X射线衍射法(PXRD)和卡尔费休滴定法对样品进行分析。观察到一些溶剂化物会脱溶剂化形成奈韦拉平的无水形式(晶型I),而其他溶剂化物则转化为半水合物。研究发现,客体溶剂与水的混溶性决定了每种溶剂化物最终转化成的奈韦拉平的稳定形式,即无水形式或半水合物形式。只有当客体溶剂具有足够的水溶性,能够使水分子进入溶剂通道并取代原来的客体时,才会发生向半水合物的转化。具有疏水性客体的溶剂化物会脱溶剂化形成无水形式。我们得出结论,在没有客体的情况下,在向单斜晶体系统和空间群P21/c(晶型I)转化的过程中,溶剂通道会丢失,因此脱溶剂化后水无法进入。